Literature DB >> 32228296

Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis.

Sohee Park1, Sang Min Lee1, Seonok Kim1, June-Goo Lee1, Sehoon Choi1, Kyung-Hyun Do1, Joon Beom Seo1.   

Abstract

Background The volume doubling time (VDT) is a key parameter in the differentiation of aggressive tumors from slow-growing tumors. How different histologic subtypes of primary lung adenocarcinomas vary in their VDT and the prognostic value of this measurement is unknown. Purpose To investigate differences in VDT between the predominant histologic subtypes of primary lung adenocarcinomas and to assess the correlation between VDT and prognosis. Materials and Methods This retrospective study included patients who underwent at least two serial CT examinations before undergoing operation between July 2010 and December 2018. Three-dimensional tumor segmentation was performed on two CT images and VDTs were calculated. VDTs were compared between predominant histologic subtypes and lesion types by using Kruskal-Wallis tests. Disease-free survival (DFS) was obtained in patients undergoing surgical procedures before July 2017. Univariable and multivariable Cox proportional hazards regression analyses were performed to determine predictors of DFS. Results Among 268 patients (mean age, 64 years ± 8 [standard deviation]; 143 men), there were 30 lepidic, 87 acinar, 109 papillary, and 42 solid or micropapillary predominant subtypes. The median VDT was 529 days (interquartile range, 278-872 days) for lung adenocarcinomas. VDTs differed across subtypes (P < .001) and were shortest in solid or micropapillary subtypes (229 days; interquartile range, 77-530 days). Solid lesions (VDT, 248 days) had shorter VDTs than subsolid lesions (part-solid lesions, 665 days; nonsolid lesions, 648 days) (P < .001). In the 148 patients (mean age, 64 years ± 8; 89 men) included in the survival analysis, 35 patients had disease recurrence and 17 patients died. VDT (<400 days) was an independent risk factor for poor DFS (hazard ratio, 2.6; P = .01) and higher TNM stage. Adding VDT to TNM stage improved model performance (C-index, 0.69 for TNM stage vs 0.77 for combined VDT class and TNM stage; P = .002). Conclusion Volume doubling times varied significantly according to the predominant histologic subtypes of lung adenocarcinoma and had additional prognostic value for disease-free survival. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Ko in this issue.

Entities:  

Year:  2020        PMID: 32228296     DOI: 10.1148/radiol.2020191835

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.

Authors:  Likun Hou; Tingting Wang; Donglai Chen; Chunyan Wu; Chang Chen; Yunlang She; Jiajun Deng; Minglei Yang; Yu Zhang; Mengmeng Zhao; Yifan Zhong; Minjie Ma; Guofang Zhao; Yongbing Chen; Dong Xie; Yuming Zhu; Qiankun Chen
Journal:  Mod Pathol       Date:  2022-01-10       Impact factor: 7.842

2.  Deep-learning reconstruction for ultra-low-dose lung CT: Volumetric measurement accuracy and reproducibility of artificial ground-glass nodules in a phantom study.

Authors:  Ryoji Mikayama; Takashi Shirasaka; Tsukasa Kojima; Yuki Sakai; Hidetake Yabuuchi; Masatoshi Kondo; Toyoyuki Kato
Journal:  Br J Radiol       Date:  2021-12-15       Impact factor: 3.039

3.  Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers.

Authors:  Jaileene Pérez-Morales; Hong Lu; Wei Mu; Ilke Tunali; Tugce Kutuk; Steven A Eschrich; Yoganand Balagurunathan; Robert J Gillies; Matthew B Schabath
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828

4.  Lung Cancer in Li-Fraumeni Syndrome.

Authors:  Kathleen Kerrigan; Jessica Chan; Jennie Vagher; Wendy Kohlmann; Anne Naumer; Jo Anson; Sara Low; Joshua Schiffman; Luke Maese
Journal:  JCO Precis Oncol       Date:  2021-03-23

5.  Prediction of the Growth Rate of Early-Stage Lung Adenocarcinoma by Radiomics.

Authors:  Mingyu Tan; Weiling Ma; Yingli Sun; Pan Gao; Xuemei Huang; Jinjuan Lu; Wufei Chen; Yue Wu; Liang Jin; Lin Tang; Kaiming Kuang; Ming Li
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

6.  Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma.

Authors:  Chia Liu; Lei-Chi Wang; Hui-Shan Chen; Yi-Chen Yeh; Po-Kuei Hsu; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu
Journal:  Thorac Cancer       Date:  2022-06-09       Impact factor: 3.223

7.  ViSTA: A Novel Network Improving Lung Adenocarcinoma Invasiveness Prediction from Follow-Up CT Series.

Authors:  Wei Zhao; Yingli Sun; Kaiming Kuang; Jiancheng Yang; Ge Li; Bingbing Ni; Yingjia Jiang; Bo Jiang; Jun Liu; Ming Li
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

8.  Determination of the optimum definition of growth evaluation for indeterminate pulmonary nodules detected in lung cancer screening.

Authors:  Jong Hyuk Lee; Eui Jin Hwang; Woo Hyeon Lim; Jin Mo Goo
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.